These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33182310)

  • 21. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
    Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
    Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone.
    Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
    Toxicol Lett; 2018 Mar; 284():184-194. PubMed ID: 29248575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging mechanisms of drug-induced phospholipidosis.
    Breiden B; Sandhoff K
    Biol Chem; 2019 Dec; 401(1):31-46. PubMed ID: 31408430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of apoptosis by cationic amphiphilic drugs amiodarone and imipramine.
    Piccotti JR; LaGattuta MS; Knight SA; Gonzales AJ; Bleavins MR
    Drug Chem Toxicol; 2005; 28(1):117-33. PubMed ID: 15720040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
    Almela MJ; Torres PA; Lozano S; Herreros E
    Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
    Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis.
    Hinkovska-Galcheva V; Treadwell T; Shillingford JM; Lee A; Abe A; Tesmer JJG; Shayman JA
    J Lipid Res; 2021; 62():100089. PubMed ID: 34087196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development.
    Casartelli A; Bonato M; Cristofori P; Crivellente F; Dal Negro G; Masotto I; Mutinelli C; Valko K; Bonfante V
    Cell Biol Toxicol; 2003 Jun; 19(3):161-76. PubMed ID: 12945744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Types of interaction of amphiphilic drugs with phospholipid vesicles.
    Joshi UM; Kodavanti PR; Coudert B; Dwyer TM; Mehendale HM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):150-7. PubMed ID: 3392651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats.
    Kodavanti UP; Lockard VG; Mehendale HM
    J Biochem Toxicol; 1990; 5(4):245-51. PubMed ID: 1965728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis.
    Nioi P; Pardo ID; Snyder RD
    Drug Chem Toxicol; 2008; 31(4):515-28. PubMed ID: 18850360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits.
    Yamagiwa Y; Haranosono Y; Nemoto S; Atsumi I; Kurata M; Kito G; Hatakeyama H; Koizumi H; Sakaki H
    J Toxicol Pathol; 2017 Apr; 30(2):135-143. PubMed ID: 28458451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for the autophagy regulator Transcription Factor EB in amiodarone-induced phospholipidosis.
    Buratta S; Urbanelli L; Ferrara G; Sagini K; Goracci L; Emiliani C
    Biochem Pharmacol; 2015 Jun; 95(3):201-9. PubMed ID: 25881747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cationic amphiphilic drug-induced phospholipidosis.
    Halliwell WH
    Toxicol Pathol; 1997; 25(1):53-60. PubMed ID: 9061852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
    Reasor MJ
    Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.